inhibition of calcium-triggered secretion by hydrocarbon-stapled peptides Screening of Hydrocarbon-Stapled Peptides for Inhibition of Calcium-Triggered Exocytosis - dr-v-skin-renew-peptide-retinol-serum SP9 acts by binding to the Ca2+sensor synaptotagmin-2 Inhibition of Calcium-Triggered Secretion by Hydrocarbon-Stapled Peptides: A Novel Therapeutic Avenue

net-charge-of-peptide-at-ph-8 The intricate process of cellular secretion, a fundamental biological mechanism, is tightly regulated by the influx of calcium ions. This calcium-triggered secretion plays a critical role in numerous physiological functions, from neurotransmission to the release of hormones and mucus. However, dysregulation of this process can lead to various pathologies, such as excessive mucus production in airway diseases.Publications - FB10 Recent scientific advancements have introduced a promising class of molecules, hydrocarbon-stapled peptides, as potent inhibitors of this calcium-dependent secretory pathway.

At the forefront of this research is the development of hydrocarbon-stapled peptides designed to specifically interfere with the molecular machinery that orchestrates calcium-triggered secretion. These innovative peptides are engineered by introducing a stable hydrocarbon linker, or "staple," into their structure. This stapling technique constrains the peptide into a specific alpha-helical conformation, significantly enhancing its stability, cell permeability, and ability to interact with its molecular targets.2022年4月6日—SP9 acts by binding to the Ca2+sensor synaptotagmin-2and disrupting its interaction with the SNARE complex, thus inhibiting Ca2+-triggered ...

A key breakthrough in understanding the inhibition of calcium-triggered secretion lies in identifying the critical molecular interfaces involved. Research has demonstrated that certain hydrocarbon-stapled peptides can effectively disrupt calcium-triggered membrane fusion by targeting a "primary interfaceStapled peptides inhibit both Ca²⁺-independent and Ca²." This interface is crucial for the assembly of protein complexes, such as the SNARE complex and synaptotagmin-2, which are essential for vesicle docking and fusion with the plasma membrane upon calcium influx. By interfering with this primary interface, these stapled peptides can effectively block the downstream events leading to exocytosis.

For instance, the hydrocarbon-stapled peptide known as SP9 has shown remarkable efficacy.“Stapled peptides” arepeptidesconstrained into an α-helix through an artificial cross-link, typically ahydrocarbonstaple between i and i + 4 residues. SP9 acts by binding to the Ca2+ sensor synaptotagmin-2 and disrupting its interaction with the SNARE complex, thus inhibiting Ca2+-triggered exocytosis. This targeted approach offers a significant advantage over less specific interventions. The research, including studies published in prestigious journals like *Nature*, highlights that these hydrocarbon-stapled peptides can be used to reduce both stimulated neurotransmitter release and mucin secretion. This finding has significant implications for treating conditions characterized by excessive secretion, such as chronic obstructive pulmonary disease (COPD) and asthma, where hypersecretion of mucus leads to airway obstruction.2022年5月11日—Hydrocarbon-stapled peptides that interfere with the primary interfaceconsequently inhibit Ca 2+ -triggered exocytosis.

The screening of hydrocarbon-stapled peptides for inhibition of calcium-triggered exocytosis has identified molecules that can modulate these secretory pathways.2022年5月11日—Hydrocarbon-stapled peptides that interfere with the primary interfaceconsequently inhibit Ca 2+ -triggered exocytosis. These peptides have been shown to interfere with the synaptotagmin-2/SNARE complex primary interface, suggesting their potential as therapeutic agents. The hydrocarbon backbone of these stapled peptides contributes to their ability to penetrate cell membranes and exert their inhibitory effects intracellularlyDiscovery of a drug to treat airway mucus hypersecretion.

Furthermore, the research extends to exploring the potential of stapled peptides in various biological contexts.Pharmaceutical engineering - Central South University Studies have investigated their ability to inhibit both Ca2+-independent and Ca2+-triggered content mixing with reconstituted neuronal SNAREs and Syt1. The development of such stapled peptides represents a significant advancement in the field of pharmaceutical engineering and the design of functional peptide-based biomaterials. The precise design of these hydrocarbon-stapled short alpha-helical peptides with different anchoring residues is crucial for optimizing their therapeutic potential.

The therapeutic promise of these hydrocarbon-stapled peptides is further underscored by their demonstrated ability to limit mucus in mouse lungs, potentially treating conditions associated with airway mucus hypersecretion. An inhaled stapled peptide drug, for example, has entered airway epithelial cells and blocked ATP-induced mucin secretion in *in vitro* and *in vivo* models. This suggests a viable route for delivering these peptides directly to the affected tissues, minimizing systemic side effects.

In summary, the inhibition of calcium-triggered secretion by hydrocarbon-stapled peptides represents a cutting-edge area of biomedical research.Inhibition of calcium-triggered secretion by hydrocarbon-stapled peptides. Nature. 2022-03-31 | Journal article. DOI: 10.1038/s41586-022-04543-1. Part of ISSN ... By precisely targeting the molecular interfaces involved in calcium-dependent exocytosis, these engineered peptides offer a novel and potent strategy for treating a range of diseases characterized by aberrant cellular secretionInhibition of calcium-triggered secretion by hydrocarbon .... The continued exploration and refinement of these hydrocarbon-stapled peptides hold immense promise for future therapeutic interventions.Stapled peptidesinhibit both Ca²⁺-independent and Ca²⁺-triggeredcontent mixing with reconstituted neuronal SNAREs and Syt1.